|The University of Texas at Austin
|Keywords / Areas of Interest
|Neuroengineering, Bioelectrics, Biomaterials, Wearable Electronics, Nanotechnology
|Nanomaterials, Protein engineering, Electronic device and systems, Neurological disease, Neuroscience, Cancer.
Recent advances in bidirectional neural interfacing enable both improved neurosciences understanding and enhanced clinical diagnosis/therapy. Dr. Wang’s research focuses on the development of new tools to modulate and record neural activity from targeted neuronal populations using minimally invasive methods. The research goal will be developing clinical neural interfacing therapies with the power and specificity afforded by optogenetics methods, using materials and electronic devices that are clinically translatable. In addition, the developed new technologies can also be applied for neuroscience research or cancer therapy. Dr. Wang obtained his undergraduate degree in Materials Science from the University of Oxford and a Ph.D. degree in Materials Science and Engineering at Stanford University. During his graduate studies with Professor Zhenan Bao, he worked on nanomaterials and polymers for flexible/wearable electronics. After his Ph.D. studies, he started his postdoctoral work with Professor Karl Deisseroth at Stanford Bioengineering, developing nanomaterial-based technologies for targeted modulation of neural activity.